Skip to main content
logo
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.520
-0.050 (-3.18%)
At close: Aug 11, 2026, 4:00 PM EDT
1.500
-0.020 (-1.32%)
After-hours: Aug 11, 2026, 5:07 PM EDT

OKYO Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Cap
801111-
Market Cap Growth
-35.14%20.14%14.70%1.98%--
Enterprise Value
59.17-19.67-0.79-0.15-1.170
Last Close Price
1.521.611.271.491.68-

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
6.680.08-0.14-0.11-0.32-
P/TBV Ratio
0.070.08----

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/EBITDA Ratio
-2.310.110.010.09-
EV/EBIT Ratio
-2.310.110.010.09-
EV/FCF Ratio
-3.310.440.020.15-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
-000-1.080
Net Debt / Equity Ratio
-1.67-1.670.280.140.89-0.92
Net Debt / EBITDA Ratio
8.242.420.220.050.140.44
Net Debt / FCF Ratio
3.473.470.860.090.240.49
Quick Ratio
2.432.430.400.210.723.17
Current Ratio
2.432.430.400.210.723.17
Return on Equity (ROE)
-72.55%-263.78%82.36%424.20%-2984.50%-131.37%
Return on Assets (ROA)
-11.94%-69.01%-160.49%-467.62%-279.20%-95.33%
Return on Capital Employed (ROCE)
-20.29%-250.52%124.10%397.08%-2965.64%-149.23%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Buyback Yield / Dilution
5.40%3.33%-34.57%-31.84%-47.74%-45.55%
Total Shareholder Return
5.40%3.33%-34.57%-31.84%-47.74%-45.55%
SEC Filings: 10-K · 10-Q